Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NSCLC × Thalidomide × Clear all

Phase

Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Multiple Myeloma 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

icotinib 2 anlotinib 2 Thalidomide 1 Drug Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡